Your browser doesn't support javascript.
loading
Tachykinin Neuropeptides and Amyloid ß (25-35) Assembly: Friend or Foe?
Liu, Xikun; Ganguly, Pritam; Jin, Yingying; Jhatro, Michael J; Shea, Joan-Emma; Buratto, Steven K; Bowers, Michael T.
Afiliación
  • Liu X; Department of Chemistry & Biochemistry, University of California Santa Barbara, Santa Barbara, California 93106, United States.
  • Ganguly P; Department of Chemistry & Biochemistry, University of California Santa Barbara, Santa Barbara, California 93106, United States.
  • Jin Y; Department of Chemistry & Biochemistry, University of California Santa Barbara, Santa Barbara, California 93106, United States.
  • Jhatro MJ; Department of Chemistry & Biochemistry, University of California Santa Barbara, Santa Barbara, California 93106, United States.
  • Shea JE; Department of Chemistry & Biochemistry, University of California Santa Barbara, Santa Barbara, California 93106, United States.
  • Buratto SK; Department of Chemistry & Biochemistry, University of California Santa Barbara, Santa Barbara, California 93106, United States.
  • Bowers MT; Department of Chemistry & Biochemistry, University of California Santa Barbara, Santa Barbara, California 93106, United States.
J Am Chem Soc ; 144(32): 14614-14626, 2022 08 17.
Article en En | MEDLINE | ID: mdl-35917596
ABSTRACT
Amyloid ß (Aß) protein is responsible for Alzheimer's disease, and one of its important fragments, Aß(25-35), is found in the brain and has been shown to be neurotoxic. Tachykinin neuropeptides, including Neuromedin K (NK), Kassinin, and Substance P, have been reported to reduce Aß(25-35)'s toxicity in cells even though they share similar primary structures with Aß(25-35). Here, we seek to understand the molecular mechanisms of how these peptides interact with Aß(25-35) and to shed light on why some peptides with similar primary structures are toxic and others nontoxic. We use both experimental and computational methods, including ion mobility mass spectrometry and enhanced-sampling replica-exchange molecular dynamics simulations, to study the aggregation pathways of Aß(25-35), NK, Kassinin, Substance P, and mixtures of the latter three with Aß(25-35). NK and Substance P were observed to remove the higher-order oligomers (i.e., hexamers and dodecamers) of Aß(25-35), which are related to its toxicity, although Substance P did so more slowly. In contrast, Kassinin was found to promote the formation of these higher-order oligomers. This result conflicts with what is expected and is elaborated on in the text. We also observe that even though they have significant structural homology with Aß(25-35), NK, Kassinin, and Substance P do not form hexamers with a ß-sheet structure like Aß(25-35). The hexamer structure of Aß(25-35) has been identified as a cylindrin, and this structure has been strongly correlated to toxic species. The reasons why the three tachykinin peptides behave so differently when mixed with Aß(25-35) are discussed.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Taquicininas / Péptidos beta-Amiloides / Enfermedad de Alzheimer Límite: Humans Idioma: En Revista: J Am Chem Soc Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: EEUU / ESTADOS UNIDOS / ESTADOS UNIDOS DA AMERICA / EUA / UNITED STATES / UNITED STATES OF AMERICA / US / USA

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Taquicininas / Péptidos beta-Amiloides / Enfermedad de Alzheimer Límite: Humans Idioma: En Revista: J Am Chem Soc Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: EEUU / ESTADOS UNIDOS / ESTADOS UNIDOS DA AMERICA / EUA / UNITED STATES / UNITED STATES OF AMERICA / US / USA